SELLAS Life Sciences (SLS) Net Cash Flow (2010 - 2026)
SELLAS Life Sciences (SLS) reported Net Cash Flow of $35.4 million for Q1 2026, up 143.61% year-over-year from $14.5 million in Q1 2025, and up 28.57% on a QoQ basis from $27.5 million in Q4 2025.
SELLAS Life Sciences (SLS) has 17 years of Net Cash Flow data on file, last reported at $35.4 million in Q1 2026.
- Quarterly Net Cash Flow rose 143.61% year-over-year to $35.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $78.7 million (up 688.77% YoY) and the FY2025 annual result came in at $57.9 million, up 409.83% from the prior year.
- Net Cash Flow rose to $35.4 million in Q1 2026 per SLS's latest filing, from $27.5 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $35.4 million in Q1 2026 and bottomed at -$9.8 million in Q3 2023.
- The 5-year median for Net Cash Flow is -$1.4 million (2023), against an average of $5.5 million.
- The widest annual swing landed in 2022, when Net Cash Flow soared 814.81%; it then slumped 396.53% in 2024.
- Tracing SLS's Net Cash Flow over 5 years: stood at -$4.2 million in 2022, then jumped by 65.92% to -$1.4 million in 2023, then plunged by 396.53% to -$7.1 million in 2024, then surged by 484.8% to $27.5 million in 2025, then grew by 28.57% to $35.4 million in 2026.
- Per Business Quant, the three latest SLS Net Cash Flow figures stand at $35.4 million (Q1 2026), $27.5 million (Q4 2025), and $19.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 60.68 Mn |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - | 35.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.35 Mn |
| Mar 31, 2026 | 35.35 Mn |
| Dec 31, 2025 | 27.49 Mn |
| Dec 31, 2025 | 27.49 Mn |
| Sep 30, 2025 | 18.99 Mn |
| Sep 30, 2025 | 18.99 Mn |
| Jun 30, 2025 | -3.10 Mn |
| Jun 30, 2025 | -3.10 Mn |
| Mar 31, 2025 | 14.51 Mn |
| Mar 31, 2025 | 14.51 Mn |
| Dec 31, 2024 | -7.15 Mn |
| Dec 31, 2024 | -7.15 Mn |
| Sep 30, 2024 | 11.88 Mn |
| Sep 30, 2024 | 11.88 Mn |
| Jun 30, 2024 | -9.27 Mn |
| Jun 30, 2024 | -9.27 Mn |
| Mar 31, 2024 | 15.89 Mn |
| Mar 31, 2024 | 15.89 Mn |
| Dec 31, 2023 | -1.44 Mn |
| Dec 31, 2023 | -1.44 Mn |
| Sep 30, 2023 | -9.84 Mn |
| Sep 30, 2023 | -9.84 Mn |
| Jun 30, 2023 | -7.60 Mn |
| Jun 30, 2023 | -7.60 Mn |
| Mar 31, 2023 | 6.78 Mn |
| Mar 31, 2023 | 6.78 Mn |
| Dec 31, 2022 | -4.22 Mn |
| Dec 31, 2022 | -4.22 Mn |
| Sep 30, 2022 | -5.64 Mn |
| Sep 30, 2022 | -5.64 Mn |
| Jun 30, 2022 | 17.24 Mn |
| Jun 30, 2022 | 17.24 Mn |
| Mar 31, 2022 | -7.10 Mn |
| Mar 31, 2022 | -7.10 Mn |
| Dec 31, 2021 | -4.93 Mn |
| Dec 31, 2021 | -4.93 Mn |
| Sep 30, 2021 | -3.64 Mn |
| Sep 30, 2021 | -3.64 Mn |
| Jun 30, 2021 | 1.88 Mn |
| Jun 30, 2021 | 1.88 Mn |
| Mar 31, 2021 | -7.27 Mn |
| Mar 31, 2021 | -7.27 Mn |
| Dec 31, 2020 | 27.10 Mn |
| Dec 31, 2020 | 27.10 Mn |
| Sep 30, 2020 | 4.86 Mn |
| Sep 30, 2020 | 4.86 Mn |
| Jun 30, 2020 | -3.41 Mn |
| Jun 30, 2020 | -3.41 Mn |
| Mar 31, 2020 | -531,000.00 |
| Mar 31, 2020 | -531,000.00 |
| Dec 31, 2019 | -1.86 Mn |
| Dec 31, 2019 | -1.86 Mn |
| Sep 30, 2019 | -3.63 Mn |
| Sep 30, 2019 | -3.63 Mn |
| Jun 30, 2019 | 10.18 Mn |
| Jun 30, 2019 | 10.18 Mn |
| Mar 31, 2019 | -2.76 Mn |
| Mar 31, 2019 | -2.76 Mn |
| Dec 31, 2018 | -4.63 Mn |
| Dec 31, 2018 | -4.63 Mn |
| Sep 30, 2018 | 87,000.00 |
| Sep 30, 2018 | 87,000.00 |
| Jun 30, 2018 | -2.09 Mn |
| Jun 30, 2018 | -2.09 Mn |
| Mar 31, 2018 | -664,000.00 |
| Mar 31, 2018 | -664,000.00 |
| Dec 31, 2017 | 10.30 Mn |
| Dec 31, 2017 | 10.30 Mn |
| Sep 30, 2017 | -2.37 Mn |
| Sep 30, 2017 | -2.37 Mn |
| Jun 30, 2017 | 2.60 Mn |
| Jun 30, 2017 | 2.60 Mn |
| Mar 31, 2017 | -3.82 Mn |
| Mar 31, 2017 | -3.82 Mn |
| Dec 31, 2016 | 626,000.00 |
| Dec 31, 2016 | 626,000.00 |
| Sep 30, 2016 | 5.91 Mn |
| Sep 30, 2016 | 5.91 Mn |
| Jun 30, 2016 | -11.48 Mn |
| Jun 30, 2016 | -11.48 Mn |
| Mar 31, 2016 | 9.50 Mn |
| Mar 31, 2016 | 9.50 Mn |
| Dec 31, 2015 | -6.47 Mn |
| Dec 31, 2015 | -6.47 Mn |
| Sep 30, 2015 | -14.45 Mn |
| Sep 30, 2015 | -14.45 Mn |
| Jun 30, 2015 | -5.16 Mn |
| Jun 30, 2015 | -5.16 Mn |
| Mar 31, 2015 | 30.77 Mn |
| Mar 31, 2015 | 30.77 Mn |
| Dec 31, 2014 | 1.44 Mn |
| Dec 31, 2014 | 1.44 Mn |
| Sep 30, 2014 | -11.12 Mn |
| Sep 30, 2014 | -11.12 Mn |
| Jun 30, 2014 | -13.27 Mn |
| Jun 30, 2014 | -13.27 Mn |
| Mar 31, 2014 | 4.64 Mn |
| Mar 31, 2014 | 4.64 Mn |
| Dec 31, 2013 | 17.58 Mn |
| Dec 31, 2013 | 17.58 Mn |
| Sep 30, 2013 | 30.48 Mn |
| Sep 30, 2013 | 30.48 Mn |
| Jun 30, 2013 | 3.44 Mn |
| Jun 30, 2013 | 3.44 Mn |
| Mar 31, 2013 | -15.33 Mn |
| Mar 31, 2013 | -15.33 Mn |
| Dec 31, 2012 | 17.38 Mn |
| Dec 31, 2012 | 17.38 Mn |
| Sep 30, 2012 | -3.81 Mn |
| Sep 30, 2012 | -3.81 Mn |
| Jun 30, 2012 | 10.61 Mn |
| Jun 30, 2012 | 10.61 Mn |
| Mar 31, 2012 | -2.73 Mn |
| Mar 31, 2012 | -2.73 Mn |
| Dec 31, 2011 | -4.26 Mn |
| Dec 31, 2011 | -4.26 Mn |
| Sep 30, 2011 | -2.24 Mn |
| Sep 30, 2011 | -2.24 Mn |
| Jun 30, 2011 | 6.82 Mn |
| Jun 30, 2011 | 6.82 Mn |
| Mar 31, 2011 | 4.22 Mn |
| Mar 31, 2011 | 4.22 Mn |
| Dec 31, 2010 | 4.06 Mn |
| Dec 31, 2010 | 4.06 Mn |
| Sep 30, 2010 | -2.26 Mn |
| Sep 30, 2010 | -2.26 Mn |